Catalyst Wire Dossier Catalyst Wire Dossier

OROS Hydromorphone Slow-Release

hydromorphone · Alza Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OROS Hydromorphone Slow-Release, covering 2010-04-27 to 2010-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain [Phase 3]

See pricing